Literature DB >> 20849979

Genetic diversity of human isolates of Mycobacterium bovis assessed by spoligotyping and Variable Number Tandem Repeat genotyping.

Nicoletta Lari1, Nicola Bimbi, Laura Rindi, Enrico Tortoli, Carlo Garzelli.   

Abstract

A collection of clinical isolates including 9 Mycobacterium bovis bacille Calmette-Guérin (BCG), 37 M. bovis and 1 isolate identified as M. bovis/caprae intermediate, recovered from humans in Tuscany, Italy, from 1990 to 2009, was genotyped by spoligotyping and Variable Number Tandem Repeat (VNTR) typing. Spoligotyping detected 15 unique profiles; the "BCG-like" SIT482/SB0120 spoligotype was largely prevalent accounting for 63.8% of isolates. VNTR typing, based on the 15 VNTR loci commonly tested for Mycobacterium tuberculosis, detected 29 unique profiles; only 8 VNTR loci (VNTR 43, MIRU 04, QUB-11b, ETR-A, VNTR 47, MIRU 31, QUB-26 and VNTR 53) provided a satisfactory allelic diversity in the VNTR analysis. Combined together, spoligotyping and VNTR typing yielded 33 unique patterns and 5 clusters including a total of 19 isolates. Clustered isolates, further typed for additional 9 VNTR loci, finally yielded 3 distinct clusters including 3 M. bovis BCG isolates each, and 1 cluster of 6 M. bovis isolates. Minimum spanning tree analysis showed that, in spite of the many distinct VNTR profiles, most M. bovis isolates displayed a high phylogenetic proximity, due to the variation of a single VNTR allele, thus indicating that the population of human M. bovis isolates in our setting is relatively homogeneous and conserved.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20849979     DOI: 10.1016/j.meegid.2010.09.004

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  9 in total

1.  Importance of confirming data on the in vivo efficacy of novel antibacterial drug regimens against various strains of Mycobacterium tuberculosis.

Authors:  Mary A De Groote; Veronica Gruppo; Lisa K Woolhiser; Ian M Orme; Janet C Gilliland; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Mycobacterium bovis BCG-Russia clinical isolate with noncanonical spoligotyping profile.

Authors:  Igor Mokrousov; Anna Vyazovaya; Yulia Potapova; Boris Vishnevsky; Tatiana Otten; Olga Narvskaya
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

3.  Limitations of spoligotyping and variable-number tandem-repeat typing for molecular tracing of Mycobacterium bovis in a high-diversity setting.

Authors:  Sabrina Rodriguez-Campos; Alicia Aranaz; Lucía de Juan; José Luis Sáez-Llorente; Beatriz Romero; Javier Bezos; Antonio Jiménez; Ana Mateos; Lucas Domínguez
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

4.  Inadequacies of minimum spanning trees in molecular epidemiology.

Authors:  Stephen J Salipante; Barry G Hall
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

5.  Splitting of a prevalent Mycobacterium bovis spoligotype by variable-number tandem-repeat typing reveals high heterogeneity in an evolving clonal group.

Authors:  Sabrina Rodriguez-Campos; Yurena Navarro; Beatriz Romero; Lucía de Juan; Javier Bezos; Ana Mateos; Paul Golby; Noel H Smith; Glyn R Hewinson; Lucas Domínguez; Darío García-de-Viedma; Alicia Aranaz
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

6.  Genetic characterization of Mycobacterium tuberculosis in the West Bank, Palestinian Territories.

Authors:  Suheir Ereqat; Abedelmajeed Nasereddin; Kifaya Azmi; Ziad Abdeen; Charles L Greenblatt; Mark Spigelman; Nalin Rastogi; Gila Kahila Bar-Gal
Journal:  BMC Res Notes       Date:  2012-06-07

7.  Five-year surveillance of human tuberculosis caused by Mycobacterium bovis in Bologna, Italy: an underestimated problem.

Authors:  G Lombardi; I Botti; M L Pacciarini; M B Boniotti; G Roncarati; P Dal Monte
Journal:  Epidemiol Infect       Date:  2017-09-07       Impact factor: 4.434

8.  Characterization of Mycobacterium bovis from Humans and Cattle in Namwala District, Zambia.

Authors:  Sydney Malama; Tone Bjordal Johansen; John Bwalya Muma; Musso Munyeme; Grace Mbulo; Adrian Muwonge; Berit Djønne; Jacques Godfroid
Journal:  Vet Med Int       Date:  2014-04-14

9.  A first insight into genetic diversity of Mycobacterium bovis isolated from extrapulmonary tuberculosis patients in South Tunisia assessed by spoligotyping and MIRU VNTR.

Authors:  Mariam Siala; Cécile Cassan; Salma Smaoui; Sana Kammoun; Chema Marouane; Sylvain Godreuil; Salma Hachicha; Emna Mhiri; Leila Slim; Dhikrayet Gamara; Férièle Messadi-Akrout; Anne-Laure Bañuls
Journal:  PLoS Negl Trop Dis       Date:  2019-09-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.